Table 2. Prevalence of four metabolic dysfunctions among adults aged 18 years and older in China, 2013–2014.
| Overall (n = 9310) | Men (n = 3792) | Women (n = 5518) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Crude prevalence (%), (95%CI) | Adjusted prevalence (%), (95%CI)* | n | Crude prevalence (%), (95%CI) | Adjusted prevalence (%), (95%CI)* | n | Crude prevalence (%), (95%CI) | Adjusted prevalence (%), (95%CI)* | |
| ① BMI≥25.0 | 3012 | 32.35(30.68–34.02) | 22.07(20.98–23.16) | 1291 | 34.05(31.47–36.63) | 17.43(29.00–33.38) | 1721 | 31.19(14.93–47.45) | 15.22(14.27–16.17) |
| ② Hyperglycemia | 2627 | 28.22(26.50–29.94) | 19.25(18.21–20.29) | 1129 | 29.77(27.10–32.44) | 15.24(24.90–29.40) | 1498 | 27.15(10.42–43.88) | 13.25(12.36–14.14) |
| ③ Hypertension | 3347 | 35.95(34.32–37.58) | 24.52(23.38–25.66) | 1508 | 39.77(37.30–42.24) | 20.36(31.18–35.48) | 1839 | 33.33(17.33–49.33) | 16.27(15.30–17.24) |
| ④ Dyslipidemia | 3276 | 35.19(33.55–36.83) | 24(22.87–25.13) | 1430 | 37.71(35.20–40.22) | 19.31(31.30–35.60) | 1846 | 33.45(17.46–49.44) | 16.33(15.35–17.31) |
| ①②③ | 774 | 8.31(6.37–10.25) | 5.67(5.06–6.28) | ||||||
| ①②④ | 634 | 6.81(4.85–8.77) | 4.65(4.09–5.21) | ||||||
| ①③④ | 753 | 8.09(6.14–10.04) | 5.52(4.92–6.12) | ||||||
| ②③④ | 693 | 7.44(5.49–9.39) | 5.08(4.50–5.66) | ||||||
| ①②③④ | 403 | 3.89(2.00–5.78) | 2.95(2.50–3.40) | ||||||
| MS | 1340 | 14.39(12.51–16.27) | 9.82(9.03–10.61) | 576 | 15.19(12.26–18.12) | 7.78(11.40–16.30) | 764 | 13.85(-4.34–32.04) | 6.76(6.10–7.42) |
Abbreviations: CI: confidence interval; BMI: Body Mass Index; MS: metabolic syndrome
*: The prevalence was adjusted by the population 2010 in China.